Click the Why column to see why an item matched the search.
Match | Type | Why |
---|
Dual HDAC and PI3K Inhibitor CUDC-907 Downregulates MYC and Suppresses Growth of MYC-dependent Cancers. | Academic Article |
Why?
|
Feng, Hui | Person |
Why?
|
Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma. | Academic Article |
Why?
|
CDK7 controls E2F- and MYC-driven proliferative and metabolic vulnerabilities in multiple myeloma. | Academic Article |
Why?
|
The Use of An EHR Patient Portal (Mychart-Epic) in Patients With Inflammatory Bowel Disease | Academic Article |
Why?
|
CKLF instigates a "cold" microenvironment to promote MYCN-mediated tumor aggressiveness. | Academic Article |
Why?
|
Targeting translation initiation by synthetic rocaglates for treating MYC-driven lymphomas. | Academic Article |
Why?
|
Horsburgh, C. | Person |
Why?
|
Editorial: Mycobacteria-Host Interactions: Genetics, Immunity, Pathology. | Academic Article |
Why?
|
Defining the Role of Glutamine Anaplerosis in High Risk MYCN-Driven Neuroblastoma | Grant |
Why?
|
Targeting CKLF as an Immunotherapeutic Approach to Treat MYCN-driven High-risk Neuroblastoma | Grant |
Why?
|
c-myc is required for osteoclast differentiation. | Academic Article |
Why?
|
Macrophages, mycobacteria and HIV: the role of cytokines in determining mycobacterial virulence and regulating viral replication. | Academic Article |
Why?
|
UFD1 contributes to MYC-mediated leukemia aggressiveness through suppression of the proapoptotic unfolded protein response. | Academic Article |
Why?
|
Comparative analysis of Mycobacterium and related Actinomycetes yields insight into the evolution of Mycobacterium tuberculosis pathogenesis. | Academic Article |
Why?
|